Sarcomatoid lung cancer (spindle/giant cells): An aggressive disease?

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 3, 2007, Pages 619-623

  Venissac, Nicolas ^a   Pop, Daniel ^a   Lassalle, Sandra ^a   Berthier, Frederic ^b   Hofman, Paul ^a   Mouroux, Jérôme ^a  

^a PASTEUR HOSPITAL   (France)

^b University of Côte d'Azur   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; KAPLAN MEIER METHOD; LUNG CANCER; MALE; MICROSCOPY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPINDLE CELL; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SARCOMA;

EID: 34548124719     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.05.031     Document Type: Article

References (22)

1. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51 (2003) 3-30
2. Sant M., Aareleid T., Berrino F., Bielska Lasota M., Carli P.M., et al., EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 suppl 5 (2003) v61-v118
3. In: Sobin L.H. (Ed). Histological typing of lung tumors. 2nd ed. (1981), World Health Organization, Geneva
4. In: Travis W.D. (Ed). Histological typing of lung tumors and pleural tumors. 3rd ed. (1999), World Health Organization, Geneva
5. Travis W.D. World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. 4th ed. (2004), World Health Organization, Geneva
6. Rossi G., Cavazza A., Sturm N., Migaldi M., Facciolongo N., Longo L., et al. Pulmonary carcinomas with pleomorphic, sarcomatoid or sarcomatous elements: a clinicopathologic and immunohistochemical study in 75 cases. Am J Surg Pathol 27 (2003) 311-324
7. Pelosi G., Fraggetta F., Nappi O., Pastorino U., Maisonneuve P., Pasini F., et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility. Am J Surg Pathol 27 (2003) 1203-1215
8. Nakajima M., Kasai T., Hashimoto H., Iwata Y., and Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 86 (1999) 608-616
9. Attanoos R.L., Papagiannis A., Suttinart P., Goddard H., Papotti M., and Gibbs A.R. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?. Histopathology 32 (1998) 225-231
10. Wick M.R., Ritter J.H., and Humphrey P.A. Sarcomatoid carcinomas of the lung: a clinicopathologic review. Am J Clin Pathol 108 (1997) 40-53
11. Ro J.Y., Chen J.L., Lee J.S., Sahin A.A., Ordonez N.G., and Ayala A.G. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer 69 (1992) 376-386
12. Ishida T., Tateishi M., Kaneko S., Yano T., Mitsudomi T., Sugimachi K., et al. Carcinosarcoma and spindle cell carcinoma of the lung: clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg 100 (1990) 844-852
13. Fishback N.F., Travis W.D., Moran C.A., Guinee Jr. D.G., McCarthy W.F., and Koss M.N. Pleomorphic (spindle/giant cell) carcinoma of the lung. Cancer 73 (1994) 2936-2945
14. Raveglia F., Mezzetti M., Panigalli T., Furia S., Giuliani L., Conforti S., et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg 78 (2004) 1742-1747
15. Ginsberg S.S., Buzaid A.C., Stern H., and Carter D. Giant cell carcinoma of the lung. Cancer 70 (1992) 606-610
16. Chang Y.L., Lee Y.C., Shih J.Y., and Wu C.T. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 34 (2001) 91-97
17. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
18. Travis W.D., Travis L.B., and Devesa S.S. Lung cancer. Cancer 75 (1995) 191-202
19. Kim T.S., Han J., Lee K.S., Jeong Y.J., Kwak S.H., Byun H.S., et al. CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients. AJR Am J Roentgenol 185 (2005) 120-125
20. Kim T.H., Kim S.J., Ryu Y.H., Lee H.J., Goo J.M., Im J.G., et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings. Radiology 232 (2004) 554-559
21. Cerfolio R.J., Bryant A.S., Ohja B., and Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
22. Naruke T., Tsuchiya R., Kondo H., and Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 71 (2001) 1759-1764